Triple-drug FDC Clinical Trial Findings In Jama

Key messages :   Telmisartan (20mg) + Amlodipine (2.5mg) + Chlorthalidone (12.5mg) FDC vs Usual Care for 6 months 1. Primary End-point : 69.5% (3-Drug-FDC) vs 55.3% (Usual-care) pts. reached target of <140 mmHg & <90 mmHg @ 6 months 2. Secondary End-point : 67.8% (3-Drug-FDC) vs 43.6% (Usual-care) pts.

reached target of <140 mmHg & <90 mmHg @ 6 weeks 3. @ 6 months, > 80% pts. were on the 3-Drug-FDC (3-Drug-FDC) vs 30% (approx.) (Usual-care … eventually reaching 3 class therapy) 4. AE profile was the same between the two groups Share your Opinions.